Mr. Chen Keng Hoong is the Executive Director of Biomed Global and serves on the board of directors of BMS Diagnostics and Biomed Diagnostics Singapore. Mr. Chen holds an honors degree in Biology from the National University of Malaysia (UKM). He began his career as a product specialist in a medical device company. He then co-founded Biomarketing Services with Mr. Ng in 1994, which is now part of Biomed Global.

From the start, Mr. Chen has been responsible for raising the standards of healthcare by focusing on critical healthcare services, especially in HIV Monitoring, Leukemia Diagnosis, Stem Cell Banking QC, HLA-Typing, and Allergy Testing. His strong record in providing innovative products and knowledge to customers has been instrumental in helping Biomed Global become a dominant brand in the healthcare industry. A testament to this is the strong partnerships Biomed Global have with principals from world renowned medical companies spanning two decades.

Mr. Chen strongly believes in building a company that improves lives, and is constantly on the look-out for innovative products that is able to improve the accuracy of diagnosis for patients. He also established and currently leads the Life Science Research Division which focuses on creating strategic partnerships with innovative suppliers in the life science industry.

Mr. Ng received his B.Sc. in Medical Technology from University of Wisconsin-Stevens Point, USA before working in Singapore. Recognizing the need to improve the standards of healthcare in Malaysia, he started Biomarketing Services (now known as Biomed Global) in 1994 together with Mr. Chen.

Biomed Global has performed strongly in Malaysia and Singapore, and expanded regionally to a number of ASEAN countries. Now, the company has grown to be a significant total solution provider for Clinical Diagnostics and Life Science Research, representing many world-renowned brands such as Becton Dickinson, Biorad and Thermofisher Scientific.

After 30 years in the industry, Mr. Ng is still very much motivated by his aspiration to build a company that enables stakeholders to have better lives. Under his leadership, Biomed Global embarked on a transformative journey to rebrand and restructure, creating a clear roadmap for growth and a commitment to continue raising the standards of healthcare in Asia.

Ms. Chew is the director and Chief Operating Officer of BMS Diagnostics, a part of the Biomed Global group. She started BMS Diagnostics together with Mr. Ng, the group CEO since September 2002.

Leveraging upon her two decades of experience in clinical diagnostics, stem cell, and blood transfusion medicine industry, she leads a team that is highly customer centric with a strong desire to improve healthcare standards in the region.

Whilst managing BMS Diagnostics, she is also passionate about setting operating standards and improving the organization’s culture and value system. The company’s accomplishments are examples of her ability to effectively lead and execute business strategies.

Ms. Chew firmly believes in pushing boundaries and not settling for less. She is also always inspired by standards and meaning. With that said, she constantly moves towards truth and moves towards what works.